top of page
RET Fusions in Thyroid Cancer: Prevalence, Histologic Features, & Detection

RET Fusions in Thyroid Cancer: Prevalence, Histologic Features, & Detection

Play Video

RET Fusions in Thyroid Cancer: Prevalence, Histologic Features, & Detection

Febuary 24th, 2021

Dr. Nikiforov.jpg

Yuri E. Nikiforov MD, PhD

Professor and Vice-Chair, Department of Pathology

Director, Division of Molecular & Genomic Pathology

Co-Director, Multidisciplinary Thyroid Center

University of Pittsburgh Medical Center

Dr. Nikiforov is Professor of Pathology and Vice Chair at the Department of Pathology, University of Pittsburgh, where he also serves as Director of the Division of Molecular & Genomic Pathology. He has published over 200 peer-reviewed articles and over 15 book chapters and is a senior editor of the textbook “Diagnostic Pathology and Molecular Genetics of the Thyroid”, now in its 3rd edition.

His research program is funded by the National Institute of Health and focused on molecular genetics of thyroid cancer, thyroid cancer diagnostics, and molecular mechanisms of chromosomal rearrangements. He is an elected member of the American Society for Clinical Investigation and a recipient of the 2007 Van Meter Award from the American Thyroid Association.

Other awards include the 2014 Light of Light Foundation Honorary Award, the 2016 Aldo Pinchera Award from the Italian Thyroid Carcinoma Observatory, the 2017 Sidney H. Ingbar Distinguished Lectureship Award from the American Thyroid Association, and the 2019 Dr. Jacques Genest Lecturer Award from The Canadian Society of Endocrinology and Metabolism.
 

Testing for RET is provided by Lighthouse, a Celerity Biosciences Subsidiary, and Funded by Loxo Oncology at Lilly

bottom of page